Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
0.3561
+0.0072 (+2.06%)
Official Closing Price
Updated: 8:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cybin Inc
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
May 03, 2022
GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
May 02, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80
Via
Benzinga
April Update: Most Cannabis Categories Declined By More Than 20%
April 30, 2022
The marijuana stock sector consists of 5 distinct categories and they each performed quite differently from one another in April..
Via
Talk Markets
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
April 29, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 28, 2022
April 28, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 4.35% at $1.20
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 27, 2022
April 27, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.77% at $0.28
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 26, 2022
April 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.61% at $0.29
Via
Benzinga
Psychedelic Drug Patenting: Still Only Scratching The Surface
April 26, 2022
Psychedelic drug R&D remains in its infancy, with dozens of psychedelics and several
Via
Talk Markets
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
April 25, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97
Via
Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
April 25, 2022
Photo by Presetbase Lightroom Presets on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
April 22, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87
Via
Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Three weeks after announcing the results of its preclinical trials for CYB003, Cybin (NYSE:CYBN) made public a partnership with Clinilabs Drug Development Corporation to take the proprietary drug to...
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) To Present At KCSA Psychedelics Conference
April 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
April 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 20, 2022
April 20, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:
Via
Benzinga
EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space
April 19, 2022
Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock. In the psychedelic space, catalysts could be...
Via
Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
April 19, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33
Via
Benzinga
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
April 19, 2022
If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you.
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 18, 2022
April 18, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28
Via
Benzinga
Cybin (NEO: CYBN) (NYSE American: CYBN) CEO Featured in Latest Power Play Release
April 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 14, 2022
April 14, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 13, 2022
April 13, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.41% at $0.24
Via
Benzinga
Cybin's (NYSE American: CYBN) (NEO: CYBN) CYB004 Demonstrates Advantages in Study
April 13, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
April 13, 2022
CYB004 is one of Cybin’s (NYSE: CYBN) proprietary second-generation psychedelics, developed to treat depression, anxiety, and ...
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 11, 2022
April 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17
Via
Benzinga
Performance Comparisons Of The 5 Cannabis Sector Categories
April 10, 2022
Here is a summary of how each of the 5 categories in the cannabis sector performed over four time periods, to highlight the different category trends that are underway.
Via
Talk Markets
Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today
April 08, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16
Via
Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
April 08, 2022
Cybin Inc. (NYSE: CYBN) announced that the World Intellectual Property Organization (WIPO) published an international patent ...
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.